Molecular cloning of the gene for a cryptosporidium sporozoite surface protein. NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Molecular cloning of the gene for a cryptosporidium sporozoite surface protein.

Int Conf AIDS. 1991 Jun 16-21;7(1):142 (abstract no. M.A.1200). Unique Identifier : AIDSLINE ICA7/1120091
Petersen C; Gut J; Leech JH; Nelson RG; Parasitology Laboratory, San Francisco General Hospital and; Departments of Medicine and Pharmaceutical Chemistry, University; of California, San Francisco, CA, USA


Abstract: OBJECTIVE: To clone the gene for a surface glycoprotein of Cryptosporidium sporozoites that is the target of a monoclonal antibody (Mab 10C6) that reacts with intracellular merozoites and the surface of sporozoites, causes shedding of the sporozoite surface coat and inhibits sporozoite invasion of Mardin-Darby Canine Kidney (MDCK) cells in vitro. METHODS: A lambda gt 11 gDNA library was screened with polyclonal mouse antisera raised to sporozoites and oocysts. Positive clones were plaque purified and used to prepare recombinant eluted antibody (REA) from the polyclonal antisera. RESULTS: REA from four clones reacted with a greater than 300 kD protein on Western blot and exhibited an IFA pattern identical to that of Mab 10C6 on fixed sporozoites. REA from all four clones reacted on Western blot with the greater than 300 kD protein immunoprecipitated by Mab 10C6. Following N-glycosidase F treatment, REA from the clones recognized multiple Cryptosporidium proteins of Mr 150-190, but Mab 10C6 did not react with any. CONCLUSIONS: The gene for a potentially protective antigen on the surface of Cryptosporidium sporozoites has been cloned and encodes a heavily glycosylated protein. The Mab 10C6 epitope requires N-linked glycosylation.
Keywords: Animal Antibodies, Monoclonal/IMMUNOLOGY Antigens, Protozoan/*GENETICS Antigens, Surface/*GENETICS Blotting, Western Cells, Cultured Cloning, Molecular Cryptosporidium/*GENETICS/IMMUNOLOGY Dogs Epitopes Glycoside Hydrolases/IMMUNOLOGY Glycosylation Membrane Glycoproteins/*GENETICS Mice Molecular Weight Precipitin Tests Protozoan Proteins/*GENETICS/IMMUNOLOGY Recombinant Proteins/IMMUNOLOGY ABSTRACTKWDanimalantibodies,monoclonal/immunologyantigens,protozoan/KWDgeneticsantigens,surface/KWDgeneticsblotting,westerncells,culturedcloning,molecularcryptosporidium/KWDgenetics/immunologydogsepitopesglycosidehydrolases/immunologyglycosylationmembraneglycoproteins/KWDgeneticsmicemolecularweightprecipitintestsprotozoanproteins/KWDgenetics/immunologyrecombinantproteins/immunologyabstract
912130
M91C3755

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .